Capricor Therapeutics (CAPR) Earnings Date, Estimates & Call Transcripts $12.38 +0.60 (+5.09%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$12.53 +0.15 (+1.18%) As of 06/16/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Capricor Therapeutics Earnings Summary Capricor Therapeutics released Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.53, which missed analysts' consensus estimates of -$0.33 by $0.20. Quarterly revenue was reported to be $2.73 million, below the consensus estimate of $3.16 million. With a trailing EPS of -$1.42, Capricor Therapeutics' earnings are expected to grow next year, from ($1.21) to ($0.75) per share. Upcoming Q2 Earnings DateAug. 6After Market ClosesEstimatedConsensus EPS (May. 13) -$0.33 Actual EPS (May. 13) -$0.53 Missed By -$0.20 Actual Revenue (May. 13) $2.73MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)CAPR Upcoming EarningsCapricor Therapeutics' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Powered by Get Capricor Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Capricor Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCAPR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CAPR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Capricor Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.35-$0.35-$0.35Q2 20252-$0.47-$0.36-$0.42Q3 20252$0.94$1.28$1.11Q4 20252-$0.39$2.83$1.22 FY 2025 7 -$0.27 $3.40 $1.57 Q1 20261-$0.27-$0.27-$0.27Q2 20261-$0.20-$0.20-$0.20Q3 20261-$0.15-$0.15-$0.15Q4 20261-$0.11-$0.11-$0.11 Capricor Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/13/2025Q1 2025-$0.33-$0.53 -$0.20-$0.53$3.16M$2.73M3/19/2025Q4 2024-$0.31-$0.16+$0.15-$0.16$9.87M$11.13M8/7/2024Q2 2024-$0.32-$0.35 -$0.03-$0.35$4.51M$3.97M5/13/2024Q1 2024-$0.11-$0.31 -$0.20-$0.31$10.00M$4.91M2/29/2024Q4 2023-$0.23-$0.02+$0.21-$0.02$5.80M$12.09M11/14/2023Q3 2023-$0.27-$0.25+$0.02-$0.25$3.33M$6.19M8/7/2023Q2 2023-$0.34-$0.29+$0.05-$0.29-$3.92M Capricor Therapeutics Earnings - Frequently Asked Questions When is Capricor Therapeutics' earnings date? Capricor Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on CAPR's earnings history. Did Capricor Therapeutics beat their earnings estimates last quarter? In the previous quarter, Capricor Therapeutics (NASDAQ:CAPR) missed the analysts' consensus estimate of ($0.33) by $0.20 with a reported earnings per share (EPS) of ($0.53). Learn more on analysts' earnings estimate vs. CAPR's actual earnings. How can I listen to Capricor Therapeutics' earnings conference call? The conference call for Capricor Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Capricor Therapeutics' conference call transcript? The conference call transcript for Capricor Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does Capricor Therapeutics generate each year? Capricor Therapeutics (NASDAQ:CAPR) has a recorded annual revenue of $17.36 million. How much profit does Capricor Therapeutics generate each year? Capricor Therapeutics (NASDAQ:CAPR) has a recorded net income of -$22.29 million. CAPR has generated -$1.42 earnings per share over the last four quarters. What is Capricor Therapeutics' EPS forecast for next year? Capricor Therapeutics' earnings are expected to grow from ($1.21) per share to ($0.75) per share in the next year. More Earnings Resources from MarketBeat Related Companies Apellis Pharmaceuticals Earnings Results Xenon Pharmaceuticals Earnings Results Amneal Pharmaceuticals Earnings Results Mirum Pharmaceuticals Earnings Results Arrowhead Pharmaceuticals Earnings Results NewAmsterdam Pharma Earnings Results Kiniksa Pharmaceuticals Earnings Results Ligand Pharmaceuticals Earnings Results Harmony Biosciences Earnings Results Belite Bio Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:CAPR) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CAPR Stock Free CAPR Stock Alerts